Postoperative radiotherapy for XXXX : results for 212 @entity1 .

@entity1 @entity137 @entity5 @entity4797 @entity34
PURPOSE: A retrospective review of @entity1 with @entity34 treated at a regional @entity5 center was performed to assess the long term efficacy and @entity137 associated with post operative radiotherapy. METHODS AND MATERIALS: Between 1950 and 1995, 212 @entity1 seen at the London Regional Cancer Centre received adjuvant radiotherapy following orchiectomy for Stage I (169) and II (43) @entity4797 . Median follow-up for the group was 7.5 years. RESULTS: Progression free, cause specific, and overall survival were 95%, 98%, and 95% at 5 years, and 94%, 98%, and 94% at 10 years respectively. An increased risk of failure was noted among @entity1 with bulky @entity34 . No other prognostic factors for relapse were identified. Late @entity137 was uncommon with only 12/212 (6%) developing any late @entity137 potentially attributable to radiotherapy. The incidence of second @entity5 (excluding second @entity5 ) was 6/212 (actuarial:1%, 1%, 6% at 5,10,15 years respectively). There was a trend toward increased acute complications for @entity1 treated with larger volumes of radiation. No prognostic factors associated with increased risk of late @entity137 or second @entity5 were identified, likely a consequence of the small number of these events. CONCLUSION: Survival and @entity137 were comparable to that reported in the literature. Post-operative radiotherapy remains a safe and efficacious adjuvant treatment for Stage I and early @entity34 .
